Risk of Major Adverse Cardiovascular Events in Patients Treated with Febuxostat Compared to Allopurinol: A Systematic Review and Meta-Analysis [0.03%]
非布司他与别嘌醇治疗患者主要心血管事件风险的系统评价和 meta 分析
Andri Reza Rahmadi,Alqa Fauzan Syahreza,Annisya Diva Shafira et al.
Andri Reza Rahmadi et al.
Introduction: To evaluate the cardiovascular safety of febuxostat compared to allopurinol in patients with gout or hyperuricemia, with a focus on Major Adverse Cardiovascular Event (MACE) outcomes. ...
Investigating the Causal Association Between Polymyalgia Rheumatica and Hypothyroidism Using Mendelian Randomization Analysis [0.03%]
使用孟德尔随机化分析方法探究多发性肌炎和甲状腺功能减退之间的因果关联
Kaige Gao,Xin Yang,Zhenyu Wang et al.
Kaige Gao et al.
Introduction: To perform a two-sample Mendelian randomization (MR) analysis to explore the potential causal relationship between polymyalgia rheumatica (PMR) and hypothyroidism. ...
Expression Profile and Clinical Significance of Ferroptosis-Related Genes in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis [0.03%]
系统性硬化症外周血单核细胞铁死亡相关基因表达谱及临床意义
Shun-Bing Wang,Tian-Yi Lei,Jian-Wei Guo et al.
Shun-Bing Wang et al.
Introduction: Systemic sclerosis (SSc) is a severe autoimmune disease marked by immune dysregulation and progressive fibrosis, yet reliable blood biomarkers remain limited. Ferroptosis, an iron‑dependent lipid peroxidati...
Effectiveness of Integrated Medicine Protocols in Treating Fibromyalgia: A Retrospective Study [0.03%]
中西医结合治疗纤维肌痛综合症回顾性研究的效果分析
Ferreri Rosaria,Cracolici Franco,Bocci Chiara et al.
Ferreri Rosaria et al.
Background: Fibromyalgia is a chronic condition characterized by a wide range of clinical presentations, making it well-suited for an integrated medicine approach that includes complementary therapies. This study aimed to...
Efficacy and Safety of Tocilizumab Biosimilars Compared to Reference Tocilizumab in the Treatment of Rheumatoid Arthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials [0.03%]
托珠单抗类似物与参照药托珠单抗治疗类风湿关节炎的疗效和安全性比较：随机对照试验的系统评价和Meta分析
Mus&#x;ab Theeb Mustafa,Ahmad Yousef Alazzam,Aws Khalid Abushanab et al.
Mus&#x;ab Theeb Mustafa et al.
Introduction: Tocilizumab biosimilars offer an innovative therapeutic option for pa-tients with rheumatoid arthritis (RA); however, their safety and efficacy compared with the refer-ence product remain undefined. This sys...
Interrelationship Between Depression and Disease Activity in Rheumatoid Arthritis: A Systematic Review and Meta-analysis Using HADS, PHQ-9, BDI, CES-D, SDS, and DAS28 Tools [0.03%]
抑郁症与类风湿关节炎病情活动相互关系的系统评价和荟萃分析：HADS、PHQ-9、BDI、CES-D、SDS及DAS28工具的应用
Khushi Lamba,Unnati Jain,Shushank Mahajan et al.
Khushi Lamba et al.
Introduction: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation and progressive destruction of cartilage and bones. In the world, RA affects 0.2-1.2% of the population, and the highes...
Causal Associations Between Nine Autoimmune Diseases and Idiopathic Thrombocytopenic Purpura: A Mendelian Randomization Study [0.03%]
九种自身免疫性疾病与特发性血小板减少性紫癜的因果关系：一项孟德尔随机化研究
Xin Yang,Kaige Gao,Suyin Yang et al.
Xin Yang et al.
Introduction: Clinical evidence suggests the presence of comorbidity between Autoimmune diseases (ADs) and secondary Idiopathic thrombocytopenic purpura (ITP), whereas the underlying causal relationship remains to be esta...
Antidrug Antibodies and Serum Etanercept Levels in Rheumatoid Arthritis: A Narrative Review [0.03%]
类风湿关节炎抗药抗体和血清依那西普水平：综述
Anfal A Abdulla,Ali A Younis,Mohammed I Aladul
Anfal A Abdulla
Introduction/objective: Etanercept is a tumor necrosis factor inhibitor used widely for rheumatoid arthritis. Because patients respond differently, clinicians have increasingly explored whether measuring drug levels and a...
Efficacy and Safety of Tocilizumab in Rheumatoid Arthritis Patients in the Middle East: Real-world Data [0.03%]
托珠单抗治疗中东地区类风湿关节炎患者的疗效和安全性：真实世界数据分析
Imad Uthman,Georges El Hasbani,Jamil Messayki et al.
Imad Uthman et al.
Introduction: Data on Tocilizumab (TCZ) efficacy and safety among RA patients in the Middle East in clinical practice remains limited. We aimed to evaluate the safety and efficacy of TCZ, as monotherapy or in combination ...
Secondary Factor X Deficiency Associated with Sjögren's Syndrome: A Rare Case Report [0.03%]
与干燥综合征相关的二次因素X缺乏症：一例罕见病例报告
Dilek Keskin,Ozlem Candan
Dilek Keskin
Background: Acquired factor X deficiency (AFXD) is considered a rare but clinically significant cause of coagulation disorders, predominantly associated with systemic AL amyloidosis. Autoimmune-mediated AFXD is very rare,...